Spigel, D R, Faivre-Finn, C, Gray, J E, Vicente, D, Planchard, D, Paz-Ares, L, Vansteenkiste, J F, Garassino, M C, Hui, R, Quantin, X, Rimner, A, Wu, Y-L, Özgüroğlu, M, Lee, K H, Kato, T, de Wit, M, Kurata, T, Reck, M, Cho, B C, Senan, S, Naidoo, J, Mann, H, Newton, M, Thiyagarajah, P & Antonia, S J 2022, ' Five-Year Survival Outcomes From the PACIFIC Trial : Durvalumab After Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer ', Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 40, no. 12, pp. 1301-1311 . https://doi.org/10.1200/JCO.21.01308 Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 40(12), 1301-1311. American Society of Clinical Oncology Spigel, D R, Faivre-Finn, C, Gray, J E, Vicente, D, Planchard, D, Paz-Ares, L, Vansteenkiste, J F, Garassino, M C, Hui, R, Quantin, X, Rimner, A, Wu, Y-L, Özgüroğlu, M, Lee, K H, Kato, T, Wit, M D, Kurata, T, Reck, M, Cho, B C, Senan, S, Naidoo, J, Mann, H, Newton, M, Thiyagarajah, P & Antonia, S J 2022, ' Five-Year Survival Outcomes From the PACIFIC Trial: Durvalumab After Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer ', Journal of Clinical Oncology . https://doi.org/10.1200/JCO.21.01308